Autism’s Social Deficits in Animal Model Are Reversed by an Anti-Cancer Drug

New research reveals the first evidence that it may be possible to use a single compound to alleviate the behavioral symptoms of autism spectrum disorder by targeting sets of genes involved in the disease. The research demonstrated that brief treatment with a very low dose of romidepsin, an anti-cancer drug, restored social deficits in animal models of autism in a sustained fashion.

Source: sciencedaily.com